Comments
Loading...

Alnylam Pharmaceuticals (ALNY) Stock Price, Quote, News & History

ALNYNASDAQ
Logo brought to you by Benzinga Data
$359.27
0.010.00%
At close: Jan 15, 4:00 PM EST
$359.00
-0.26-0.07%
Pre-Market: 7:31 AM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
265.86M
Investing Cash Flow (TTM)
420.59M
Financing Cash Flow (TTM)
-319.51M
Free Cash Flow (TTM)
221.36M
Capital Expenditure (TTM)
-44.50M
Net Change in Cash (TTM)
366.94M

Analyst Trends and Forecast

8
Sep 25
7
1
Oct 25
1
Nov 25
1
1
Dec 25
3
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$46.05B
PE Ratio (TTM)
1197.57
PE Ratio (FWD)
50.51
PEG Ratio (TTM)
-
PS Ratio (TTM)
14.87
PB Ratio (TTM)
202.93
Earnings Yield % (TTM)
0.08%
Earnings Yield % (FWD)
1.98%
EV / EBITDA (TTM)
246.73
Price / EBITDA (TTM)
255.81
Price / Free Cash Flow (TTM)
215.68
Book Value / Share
$1.77

Company Debt

Total Debt
$1.04B
LT Debt
$1.04B
LT Debt Issuance (TTM)
$646.37M
LT Debt Repayment (TTM)
-$1.14B
Total Cash
$1.49B
Debt to Equity
5.59
Issuance of Debt (TTM)
-$491.60M
Repayment of Debt (TTM)
-$1.14B

Key Statistics

Open
-
Close
$359.27
Volume / Avg.
225.00 / 1.33M
Day Range
- - -
52 Wk Range
205.87 - 495.55
Market Cap
$47.43B
P/E Ratio
1.20K
Dividend Yield
-
Exchange
NASDAQ
RSI
29
Short Interest
5.51%
Days to Cover
2.89

About

Sector
Health Care
Industry
Biotechnology
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALNY
ONC

FAQ

Q

How do I buy Alnylam Pharmaceuticals (ALNY) stock?

A

You can purchase shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Alnylam Pharmaceuticals (ALNY) competitors?

Q

What is the forecast, or price target, for Alnylam Pharmaceuticals (ALNY) stock?

A

Alnylam Pharmaceuticals has a consensus price target of $462.97.

Q

What is the current price for Alnylam Pharmaceuticals (ALNY)?

A

The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $359 last updated January 16, 2026 at 4:13 PM EST.

Q

Does Alnylam Pharmaceuticals (ALNY) pay a dividend?

A

There are no upcoming dividends for Alnylam Pharmaceuticals.

Q

When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?

A

Alnylam Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Alnylam Pharmaceuticals (ALNY) going to split?

A

There is no upcoming split for Alnylam Pharmaceuticals.

Q

What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

A

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.